Blue Owl Capital Holdings’s KalVista Pharmaceuticals KALV Stock Holding History

Blue Owl Capital Holdings’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-215,000	Closed	-$4.33M	–	84
2026 Q1	$4.33M	Sell	215,000 -145,000	-40%	-$2.34M	1.16%	23
2025 Q4	$5.81M	Buy	360,000 +235,000	+188%	+$3.11M	1.79%	16
2025 Q3	$1.52M	Buy	+125,000	New	+$1.73M	0.47%	33

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Blue Owl Capital Holdings's KALV Position: Q2 2026 in Review

Blue Owl Capital Holdings sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 215,000 shares — an estimated $4.33M sold.

Blue Owl Capital Holdings first reported a position in KALV in Q3 2025 and held it in 3 quarters. The position peaked at $5.81M in Q4 2025. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Blue Owl Capital Holdings reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Blue Owl Capital Holdings sold 215,000 KalVista Pharmaceuticals shares in Q2 2026, an estimated $4.33M.
Blue Owl Capital Holdings first reported a position in KalVista Pharmaceuticals in Q3 2025 and held it in 3 quarters.
Blue Owl Capital Holdings's KalVista Pharmaceuticals position peaked at $5.81M in Q4 2025.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Blue Owl Capital Holdings's 13F filing for Q2 2026, filed 11 Aug 2026.